These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 894193)

  • 1. Some factors affecting a commercial kit for radioimmunoassay of digoxin using tritiated digoxin.
    Boink AB; Kruyswijk HH; Willebrands AF; Maas AH
    J Clin Chem Clin Biochem; 1977 May; 15(5):261-6. PubMed ID: 894193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Maternal concentration of serum digoxin and concentration in the amniotic fluid and neonatal serum].
    Plotti G; Rigon G; Nicolanti G; Garzetti G; Angelozzi P; Cataldi L
    Recenti Prog Med; 1989 Mar; 80(3):165-9. PubMed ID: 2740607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digoxin- and digitoxin-like immunoreactive substances in amniotic fluid, cord blood, and serum of neonates.
    Ebara H; Suzuki S; Nagashima K; Koizumi T; Nishida A; Kanbe Y; Kuroume T
    Pediatr Res; 1986 Jan; 20(1):28-31. PubMed ID: 3511439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross reactivity of digitoxin and spironolactone in two radioimmunoassays for serum digoxin.
    Müller H; Bräuer H; Resch B
    Clin Chem; 1978 Apr; 24(4):706-9. PubMed ID: 639280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A simplified radioimmunoassay for digoxin determination using a 125-j-labelled, solid-phase kit (author's transl)].
    Doering W; Blümel E
    Klin Wochenschr; 1978 May; 56(10):497-502. PubMed ID: 651281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical appraisal of a further three new commercial digoxin radioimmunoassay kits with reference to cross-reacting substances.
    Wood WG; Wachter C
    J Clin Chem Clin Biochem; 1979 Feb; 17(2):77-83. PubMed ID: 422947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical experiences with the determination of the plasma digoxin level].
    Jambroes G; Kruyswijk HH; Boink AB; Maas AH; Willebrands AF
    Ned Tijdschr Geneeskd; 1973 Dec; 117(48):1802-8. PubMed ID: 4788672
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of oral spironolactone and intravenous canrenoate-K on the digoxin radioimmunoassay.
    Lichey J; Schröder R; Rietbrock N
    Int J Clin Pharmacol Biopharm; 1977 Dec; 15(12):557-9. PubMed ID: 598949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of digoxin by radioimmunoassay.
    Walsh PR; Crawford JF; Hawker CD
    Ann Clin Lab Sci; 1977; 7(1):79-87. PubMed ID: 836005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous digitalis-like immunoreactive substances in cord serum characterized by anti-digitoxin and anti-digoxin antibodies. Effect of modulated incubation conditions.
    Scherrmann JM; Sandouk P; Guedeney X
    Clin Biochem; 1986 Aug; 19(4):201-4. PubMed ID: 3530526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of assay conditions on cross reactivity of digoxin-like immunoreactive substance(s) with radioimmunoassay kits.
    Pudek MR; Seccombe DW; Jacobson BE; Humphries K
    Clin Chem; 1985 Nov; 31(11):1806-10. PubMed ID: 4053349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of the homogeneous enzyme immunoassay (EMIT) and two radioimmunoassays (RIA's) for digoxin.
    Drost RH; Plomp TA; Teunissen AJ; Maes AH; Maes RA
    Clin Chim Acta; 1977 Sep; 79(3):557-67. PubMed ID: 330027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of spironolactone and canrenone on the digoxin radioimmunoassay.
    Huffman DH
    Res Commun Chem Pathol Pharmacol; 1974 Dec; 9(4):787-90. PubMed ID: 4477402
    [No Abstract]   [Full Text] [Related]  

  • 14. Variability among commercially available digoxin radioimmunoassay kits in cross reactivity to dihydrodigoxin.
    Kramer WG; Kinnear NL; Morgan HK
    Clin Chem; 1978 Jan; 24(1):155-7. PubMed ID: 618648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunoassay of digoxin in serum using monoclonal antibodies and assessment of interference by digoxin-like immunoreactive substances.
    Loucari-Yiannakou E; Yiannakou L; Souvatzoglou A; Diamandis EP
    Ther Drug Monit; 1990 Mar; 12(2):195-200. PubMed ID: 2315977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of radioimmunoassay for measurement of serum digoxin in digitalized patients using novel anti-digoxin antiserum.
    Ikeda Y; Araki T; Takimoto H; Fujii Y
    Biol Pharm Bull; 2002 Apr; 25(4):422-5. PubMed ID: 11995917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of spironolactone and its metabolite canrenone on serum digoxin assays.
    Foukaridis GN
    Ther Drug Monit; 1990 Jan; 12(1):82-4. PubMed ID: 2305425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suitability of antidigoxin antiserum for digoxin in plant extracts.
    Nickel SL; Staba EJ
    Lloydia; 1977; 40(3):231-5. PubMed ID: 561284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economical modification of a radioimmunoassay of digoxin with negligible interference from cord and neonatal sera.
    Lee HS; Yeoh TS; Lee AS; Ho NK; Ti TY
    Ther Drug Monit; 1986; 8(3):377-9. PubMed ID: 3750379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitive radioimmunoassay for digoxin in plasma and urine.
    Wagner JG; Hallmark MR; Sakmar E; Ayres JW
    Steroids; 1977 Jun; 29(6):787-807. PubMed ID: 910251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.